Arena Pharmaceuticals (ARNA) in Focus: Stock Rallies 7.2% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Arena Pharmaceuticals ( ARNA ) was a big mover last session, as the company saw its shares a rise a little over 7% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up over 29.2% in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate has hit a plateau. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Arena Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Actelion Ltd. ( ALIOF ), Gentium S.p.A ( GENT ) and Affymetrix Inc. ( AFFX ). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

AFFYMETRIX INC (AFFX): Free Stock Analysis Report


ARENA PHARMA (ARNA): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: AFFX , ALIOF , ARNA , GENT

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by